For research and educational purposes only. Not medical advice.
SLU-PP-332 Reference
Educational, not medical advice reference for SLU-PP-332: Metabolic, Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also k…
Reference summary
Published work is preclinical, focused on mechanism-of-action in ERR signaling and rodent phenotypes (improved endurance and reduced fat mass in diet-induced obesity). There is no published human clinical program.
- Categories
- Metabolic, Fat Loss
- Aliases
- ERR pan-agonist, Exercise-mimetic small molecule, Non-peptide small molecule
- Evidence posture
- preclinical — Rodent exercise-mimetic data only. No published human clinical program for SLU-PP-332. Community weight-loss / endurance framing extrapolates from mouse models.
- Regulatory status
- No FDA-approved SLU-PP-332 drug label. SLU-PP-332 is a non-peptide small-molecule pan-agonist of the estrogen-related receptor (ERR) family studied as an exercise-mimetic in rodent obesity and metabolic models.
- Content review status
- research reference